CRN Announces Innovation Exchange 2025 Lineup

The Council for Responsible Nutrition (CRN) announced the lineup of presentations slated for its Innovation Exchange, which is part of the association’s Convergence ’25 event taking place in St. Louis Oct. 8-10.

The lineup includes:

• “Lactobacillus gasseri CP2305, an alternative dietary supplement for mood and sleep through the modulation of the gut microbiome,” presented by ADM.
• “Empowering brain health: The nexus of science, form, and dosage,” presented by Balchem Corporation.
• “Redesigning nutraceuticals efficacy: How TurmXTRA and Prolanza deliver measurable health gains in small doses,” presented by Nutriventia.
• “Precision wellness at scale: Powered by AI and crowdsourced clinical trials,” presented by Radicle Science.
• “Metabolaid: A clinically proven botanical targeting blood pressure, satiety hormones, AMPK and the gut microbiome,” presented by SuanNutra.
• “Psychobiotics for neurotransmitter regulation: Clinical advances in gut-brain axis interventions,” presented by Verb Biotics.

“The presentations for CRN’s 2025 Innovation Exchange reveal exciting science-based breakthroughs for forward-looking dietary supplement and functional food formulations,” said Michael Martman, PhD, VP of research and development at Plexus Worldwide and Innovation Exchange steering committee member. “We look forward to hearing from these creative, transformational companies on their ahead-of-the-curve innovations and invite industry stakeholders to join us this fall for this exploration.”

“Innovation Exchange reflects CRN’s commitment to support members’ innovation for meeting consumer needs and desires when it comes to their wellness regimens,” said Luke Huber, ND, vice president of scientific and regulatory affairs at CRN. “This year’s lineup demonstrates the strength of CRN members in driving progress, from innovations in clinical research methods to microbiome-focused ingredients, and offers attendees a front-row seat to the future of health and nutrition solutions.”